 The FDA has granted Fast Track designation to Veru Incs VERU sabizabulin, oral cytoskeleton disruptor, to combat COVID-19 infection and the cytokine storm responsible for Acute Respiratory Distress Syndrome ARDS and death. ALERT Nic Chahine shares his Bear Market Beating options trading strategy. 